Archive of Pharmacy publishes original scientific and professional articles from the following fields in pharmacy: medicinal chemistry, pharmaceutical analysis, pharmacognosy, pharmaceutical technology, industrial pharmacy, cosmetology, biopharmacy - bioanalytical and biopharmaceutical research, pharmacokinetics, drug metabolism, pharmacotherapy, biochemistry, medicinal biochemistry, immunology, pathophysiology, microbiology, experimental and clinical pharmacology, toxicology, bromatology, pharmaceutical practice, organization of pharmaceutical practice, pharmacoeconomics, pharmaceutical legislation, quality assurance in pharmacy, history of pharmacy, ethics, pharmacoepidemiology and clinical pharmacy.
The manuscripts are classified into the following categories:
a) review articles which can represent an overview of a specific problem or an overall overview of a certain, current topic in pharmacy
b) original scientific articles contain results of original, unpublished research
c) professional articles can have a bibliographic or experimental character
d) short communications contain results of original, unpublished research.
e) Letter to the editor
Categories Letter to the editor and Report publish novelties from scientific and professional meetings as well as information about them, information from international pharmaceutical journals, professional news, reviews of new books, biographical and professional notes (anniversaries, awards, obituaries), as well as announcements of the Pharmaceutical Association of Serbia and its professional sections.
Articles are published primarily in English, and exceptionally in Serbian.
The manuscript and accompanying files should be submitted on-line using editorial system ASISTENT (http://aseestant.ceon.rs/index.php/arhfarm). In order to successfully submit manuscript, please register in the system ASISTENT and enter all required information. If you are already registered as an author, reviewer, editor of other journal, please do not register again. You can log in with by entering your user name and password. If you wish to change your email address, password or any other detail, please go to »Forgot your passward?« button or to your profile to change necessary data. For any additional question authors can contact Editor-in-Chief, prof. dr Radica Stepanović Petrović (e-mail:firstname.lastname@example.org).
No fee is paid to the authors for published articles and copyright is transferred to the Publisher. Permission for the reproduction or republication of materials from articles published in the Archive of Pharmacy should be sought from the Publisher.
Cover letter. Alongside the manuscript, a cover letter must be submitted. The letter must be signed by all authors, or by the corresponding author (with previous consent from all authors). The letter should include a statement that the work described in the article has not been published previously, that the article is not under consideration for publication elsewhere and that the manuscript has been read and approved by all the authors who fulfill the criteria for authorship. Additionally, copies of permissions for the reproduction of previously published materials and illustrations should be submitted.
The articles are reviewed by two independent reviewers. The names of the reviewers are confidential. Upon reception of the review, the author is obliged to correct the paper according to the reviewers’ suggestions until the deadline indicated by the Editorial decision. The proof is sent to the authors who need to review it within 2 (two) working days.
PREPARATION OF THE MANUSCRIPT
Manuscripts should be typed on an A4 paper format, double-spaced, with 3 cm margins. Font Times New Roman, font size 12 pt. Review articles should not exceed 30 pages, whereas original scientific and professional articles should not exceed 20 pages. Short communications should be written on up to 10 pages.
The content of individual sections (described in the following text) refers primarily to scientific articles; review and professional articles should have appropriate subtitles.
The manuscript has to be arranged as follows:
I – Front page
1. The title should be short, clear, informative and without abbreviations and formulae, with full names of the authors, names of the authors’ institutions and the exact address of the corresponding author.
2. Author names – present full names and surnames of the authors, with the authors' affiliation marked with an Arabic number in superscript and the corresponding author marked with an asterisk.
3. Institution names are presented as full (official) names, with postal addresses, underneath the names of the authors. The stated institutions should refer to the place where the actual work was done (for scientific papers, short communications and experimental professional papers); for other types of publications, state the authors’ place of work at the time of manuscript preparation.
4. The corresponding author should be clearly specified. The corresponding author’s affiliation should be stated, as well as their e-mail address and telephone number.
II - Abstract
5. Abstract, non-structured, up to 200 words, should be prepared on a separate page and include all important facts presented in the article, including the main conclusion. Papers written in English should have an abstract in English, as well as an abstract in Serbian presented on the following page. Papers written in Serbian should have an abstract in Serbian, as well as an abstract in English presented on the following page.
6. Key words should be selected in a way that clearly indicates the research problem and the results; up to 5 (five) key words should be written both in Serbian in English, underneath the appropriate abstract.
III – Manuscript
7. The introduction should be written in a clear and concise manner, and include the essence of the research problem and related references, as well as the aim of the study.
8. The Experimental part should include the description of subjects, materials and methods used in the experiment. If methods are widely known and described in the literature, only reference(s) containing a more detailed description should be cited. New or modified methods should be fully described. Methods used for calculation of parameters and statistical analyses should be stated as well. All abbreviations must be explained the first time they are used in the manuscript. For drugs, generic names should be used, and proprietary names only if necessary. International units of measurement (SI units) should be used, unless other types of units are indicated.
9. The Results should be clear and precise, and contain the statistical methods used for analysis.
10. The Discussion includes the interpretation of the results and their comparison to literature data. At the end of this part, all conclusions obtained during the research need to be specified. The last two parts of the manuscript can be presented together as a single Results and Discussion section.
11. Acknowledgements contain information about or words of authors’ appreciation for scientific, professional, technical or financial help. Acknowledgements are presented after the Discussion section, or after the Results and Discussion section. If the paper is part of a project, the project number should be listed using square brackets [project number XXXX].
12. References – more details in the following text.
IV – Equations/Formulae
The meaning of symbols should be explained on first use, just under the equation/formula. Equations/formulae should be numbered in order of appearance, on the right side, using round brackets. Ion valence should be listed as e.g. Ca2+, not as Ca++. Isotope number should be written before the chemical element symbol, e.g. 18O. One should avoid repeating the chemical formula too many times. Full chemical names of substances should be written. In cases of very long chemical names, they can be abbreviated, by inserting the chemical element symbol.
V - References
References in text are marked using Arabic numerals, inside round brackets (). The list of references should be presented at the end of the manuscript, in the order in which references appear in the text. Journal names should be abbreviated according to the Index Medicus. The Vancouver numbered referencing style should be used, according to the rules established by the International Committee of Medical Journal Editors http://www.icmje.org/; also known as – Uniform Requirements for Manuscripts Submitted to Biomedical Journals. If there are more than six authors, list the first six and add et al.
a) Articles in journals:
Petitti DB, Crooks VC, Buckwalter JG, Chiu V. Blood pressure levels before dementia. Arch Neurol. 2005;62(1):112-6.
In cases where the reference has no volume number and/or page numbers, the doi number must be listed:
Asín-Prieto E, Rodríguez-Gascón A, Isla A. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents. J Infect Chemother. doi: 10.1016/j.jiac.2015.02.001.
Special types of published journals
- Special edition of the journal
Pekcan O, Kara S. Cation effect on thermal transition of iota-carrageenan: a photon transmission study. J Biomater Sci (Polym Ed). 2005;16(3):317-33.
- Special number of the journal
Scott JD. The protease inhibitor drugs. Posit Aware. 2005 Winter;Spec No:16-9. Mar Molinero F, Ramos Amador JT, Sanchez Diaz JI. Terapeutica antimicrobiana en las infecciones respiratorias de vias bajas [Antibacterial therapy in lower respiratory tract infections]. An Esp Pediatr. 1997;Spec No 2:207-8. (in Spanish).
- Journal supplement
Beyond menopause. Life after estrogen. Mayo Clin Health Lett. 2005;50(3S):1-8.
b) Books and monographs:
One or multiple authors
Jenkins PF. Making sense of the chest x-ray: a hands-on guide. New York: Oxford University Press; 2005. 194 p.
Eyre HJ, Lange DP, Morris LB. Informed decisions: the complete book of cancer diagnosis, treatment, and recovery. 2nd ed. Atlanta: American Cancer Society; 2002. 768 p.
Book with authors and editors/translators
Martin EW. Hazards of medication. 2nd ed. Ruskin A, Napke E, Alexander S, Kelsey FO, Farage DJ, Mills DH, Elkas RW, editors. Philadelphia: Lippincott; 1978; p. 686.
Whiteside TL, Heberman RB. Effectors of immunity and rationale for immunotherapy. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC Jr, Gansler TS, Holland JF, Frei E 3rd, editors. Cancer medicine 6. Hamilton (ON): BC Decker Inc; 2003; p. 221-8.
Proceedings paper from a scientific meeting
van Pelt J, Kamermans M, Levelt CN, van Ooyen A, Ramakers GJA, Roelfsema PR, editors. Development, dynamics, and pathology of neuronal networks: from molecules to functional circuits. Proceedings of the 23rd International Summer School of Brain Research; 2003 Aug 25-29; Royal Netherlands Academy of Arts and Sciences, Amsterdam, the Netherlands. Amsterdam: Elsevier; 2005; 385 p. (Progress in brain research; vol. 147).
c) Other types of references:
Dissertations and master theses
Jones DL. The role of physical activity on the need for revision total knee arthroplasty in individuals with osteoarthritis of the knee [dissertation]. [Pittsburgh (PA)]: University of Pittsburgh; 2001. 436 p.
Roguskie JM. The role of Pseudomonas aeruginosa 1244 pilin glycan in virulence [master's thesis]. [Pittsburgh (PA)]: Duquesne University; 2005. 111 p.
Laws and directives
Zakon o zdravstvenoj zaštiti. Službeni glasnik RS 25/219.
European Commission. EC Guide to Good Manufacturing Practice for Medicinal Products and Active Pharmaceutical Ingredients. 4th ed. Aulendorf: ECV-Editio Cantor Verlag, 2002; 26-43.
World Health Organisation. Quality assurance of pharmaceuticals. A compendium of guidelines and related materials. Volume 2 - Good manufacturing practices and inspection. Geneva, 1999.
International Organisation for Standardisation/International Electrotehnical Commission (ISO/ IEC). Guide 73. Risk management – Vocabulary – Guidelines for use in standards. 1st ed. 2002.
European Pharmacopoeia. 9th ed, Strasbourg: Council of Europe, 2016.
Reference to a website
Complementary/Integrative Medicine [Internet]. Houston: University of Texas, M. D. Anderson Cancer Center; c2007 [cited 2007 Feb 21]. Available from: http://www.mdanderson.org/departments/CIMER/.
Reference to a website with authors
Hooper JF. Psychiatry & the Law: Forensic Psychiatric Resource Page [Internet]. Tuscaloosa (AL): University of Alabama, Department of Psychiatry and Neurology; 1999 Jan 1 [updated 2006 Jul 8; cited 2007 Feb 23]. Available from: http://bama.ua.edu/~jhooper/.
VI – Figures and tables
Figures and Tables should be provided on a separate page, after the reference list and labeled in the same way as in the text.
All figure/table captions/legends need to be prepared in Serbian and in English, and placed before/after the Tables and Figures.
Tables should be numbered with Roman numerals and with the captions above the tables. Tables should be created and attached as Word documents, not as figures/images. Rows and columns should not be colored or shadowed.
Figures are numbered with Arabic numerals, with the legend under the figure (legends are typed on a separate page). Every figure (photograph, drawing, sketch) should have a title/caption. The title/caption needs to be short, and placed under the figure, never on the figure itself. The amount of text on figures should be kept at a minimum and used only to explain used symbols or abbreviations. Figures (in color or black-white) should be saved in TIFF (or JPG) format, with a resolution of at least 300 dpi.
Review articles provide a brief outline of the subject matter. Regarding the scoup, the review articles should be sufficiently broad in scope or specific enough to permit discussion at an appropriate depth enabeling critical expert opinion on the proposed topic.
Original scientific paper
Article is scientific paper that contain original and unpublished research.
Professional article represents bibliographic or experimental article engaged in specific expert issue(s).
Short communication contains original, unpublished research shorter in length compared to original scientific ariticles.
The report may include, in more or less detail, information on the held scientific or professional meeting. It may also include information from international pharmaceutical journals; news from the pharmaceutical profession; views of new books; biographical and professional records (anniversaries, awards, in memoriam), as well as notices from the Federation of Serbian Pharmaceutical Associations and professional sections of the Federation.